Showing results (121-130 of 136) with videos related to
Sort By:
Pageof 14
Oncology Letters|June 20, 2022
Polymethoxylated flavone sudachitin is a safe anticancer adjuvant that targets glycolysis in cancer-associated fibroblastsShuhai Chen, Masaaki Nishi, Yuji Morine, et al.The Journal of Medical Investigation : JMI|November 11, 2021
Usefulness of a multidisciplinary surgical site infection team in colorectal surgeryShohei Eto, Kozo Yoshikawa, Yukako Takehara, et al.Surgical Endoscopy|April 5, 2023
Transanal lateral lymph node dissection with intraoperative hologram support in low rectal cancerTakuya Tokunaga, Maki Sugimoto, Yu Saito, et al.Annals of Gastroenterological Surgery|June 5, 2018
Blue light-emitting diodes induce autophagy in colon cancer cells by Opsin 3Toshiaki Yoshimoto, Yuji Morine, Chie Takasu, et al.International Cancer Conference Journal|January 8, 2024
Conversion surgery after successful response to chemotherapy (S-1 + oxaliplatin + nivolumab) in a patient with stage IV gastric cancer with peritoneal metastasis (P1, CY1): a case reportTakayuki Noma, Masaaki Nishi, Chie Takasu, et al.Surgical Case Reports|April 18, 2022
Four cases of gastric adenocarcinoma and proximal polyposis of the stomach treated by robotic total gastrectomyYosuke Iwakawa, Kozo Yoshikawa, Koichi Okamoto, et al.International Cancer Conference Journal|June 7, 2022
Gastric carcinoma with lymphoid stroma derived from hamartomatous inverted polyp with osteoclast-like giant cells: a case reportShoko Yamashita, Masaaki Nishi, Kozo Yoshikawa, et al.Nutrition (Burbank, Los Angeles County, Calif.)|July 31, 2020
Impact of phase angle on postoperative prognosis in patients with gastrointestinal and hepatobiliary-pancreatic cancerSonoko Yasui-Yamada, Yu Oiwa, Yu Saito, et al.Nutrients|March 10, 2022
Development and Validation of Cutoff Value for Reduced Muscle Mass for GLIM Criteria in Patients with Gastrointestinal and Hepatobiliary-Pancreatic CancersMami Takimoto, Sonoko Yasui-Yamada, Nanami Nasu, et al.International Journal of Clinical Oncology|January 24, 2021
A multicenter phase II trial of preoperative chemoradiotherapy with S-1 plus oxaliplatin and bevacizumab for locally advanced rectal cancerJun Higashijima, Takuya Tokunaga, Toshiaki Yoshimoto, et al.Pageof 14